Lv41
540 积分 2021-02-20 加入
An update on the importance of plasma protein binding in drug discovery and development
1小时前
已完结
An update on the importance of plasma protein binding in drug discovery and development
5天前
已完结
Cardiac and Kidney Adverse Effects of HIF Prolyl-Hydroxylase Inhibitors for Anemia in Patients With CKD Not Receiving Dialysis: A Systematic Review and Meta-analysis
1个月前
已完结
A novel scenario in the therapeutic management of anemia of chronic kidney disease: placement and use of roxadustat
1个月前
已完结
Pharmacokinetics, Pharmacodynamics, and Safety Evaluation of the Novel HIF-PH Inhibitor Enarodustat: An Open-Label Phase I Study in Healthy Chinese Participants
1个月前
已完结
The preclinical and phase 1 development of the novel oral cathepsin C inhibitor BI 1291583
2个月前
已关闭
A profile of brensocatib for non-cystic fibrosis bronchiectasis
2个月前
已完结
Comparing the pharmacokinetic and pharmacodynamic qualities of current and future therapies for uterine fibroids
3个月前
已完结
Suppressive effects of linzagolix, a novel non‐peptide antagonist of gonadotropin‐releasing hormone receptors, in experimental endometriosis model rats
3个月前
已完结
Pharmacological characterization of linzagolix, a novel, orally active, non‐peptide antagonist of gonadotropin‐releasing hormone receptors
3个月前
已完结
皖公网安备34019202002308
